News Senior FDA resignations gut drug advertising function Two senior officials at the FDA's drug promotion office have resigned, leading to speculation that a clampdown on some advertising may be on the way.
News GSK reprimanded over "shocking error" in Omjjara info A complaint against GSK alleging a major breach of the pharma industry's code of practice on prescribing information has been upheld by the PMCPA.
News EVERSANA adds AI to medical, legal and regulatory reviews A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.
News Novo Nordisk returns to ABPI fold after two-year suspension Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."
News Novo Nordisk follows Lilly into DTC obesity drug market Novo Nordisk has launched direct-to-consumer sales of its obesity drug Wegovy for uninsured or under-insured people at $499 per month.
News Lilly launches discounted high-strength Zepbound vials in US Eli Lilly's drive to provide as many treatment options as possible for its obesity drug Zepbound has continued with the launch of new high-dose vials.
News Ozempic patient blinded by NAION sues Novo Nordisk Novo Nordisk has seen its first lawsuit over the proposed link between Ozempic and the rare eye disorder NAION.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl